Gene Fusions in Pediatric Sarcomas (R21)

Funding Opportunity PA-16-252 from the NIH Guide for Grants and Contracts. The overall goal of this funding opportunity announcement (FOA) is to encourage research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding